Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyoko Nishikimi

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Gynecologic Oncology|August 13, 2017
Survival and safety associated with aggressive surgery for stage III/IV epithelial ovarian cancer: A single institution observation studyShinichi Tate, Kazuyoshi Kato, Kyoko Nishikimi, et al.
Anticancer Research|April 30, 2022
Bevacizumab-based Salvage Chemotherapy Improves Survival Outcomes for Patients With Brain Metastasis from Ovarian CancerShinichi Tate, Kyoko Nishikimi, Ayumu Matsuoka, et al.
Acta Cytologica|May 22, 2022
Influence of Estradiol-Producing Ovarian Tumors on the Maturation Index of Cervical Cytology in Postmenopausal WomenAyumu Matsuoka, Shinichi Tate, Satoyo Otsuka, et al.
Cancers|August 27, 2021
Surgical Techniques and Outcomes of Colorectal Anastomosis after Left Hemicolectomy with Low Anterior Rectal Resection for Advanced Ovarian CancerKyoko Nishikimi, Shinichi Tate, Ayumu Matsuoka, et al.
In Vivo (Athens, Greece)|September 13, 2022
Validity of the 2014 FIGO Stage IIIA1 Subclassification for Ovarian, Fallopian Tube, and Peritoneal CancersAyumu Matsuoka, Shinichi Tate, Kyoko Nishikimi, et al.
Gynecologic Oncology|March 21, 2020
Metastatic peripancreatic lymph nodes resection during primary debulking surgery for primary peritoneal serous carcinomaKyoko Nishikimi, Shinichi Tate, Ayumu Matsuoka, et al.
Cancers|September 23, 2022
Serum FSH as a Useful Marker for the Differential Diagnosis of Ovarian Granulosa Cell TumorsAyumu Matsuoka, Shinichi Tate, Kyoko Nishikimi, et al.
Journal of Gynecologic Oncology|February 28, 2025
Intra- and postoperative complications associated with diaphragmatic surgery for advanced ovarian cancerKyoko Nishikimi, Shinichi Tate, Ayumu Matsuoka, et al.
Journal of Gynecologic Oncology|November 13, 2020
Tailored-dose chemotherapy with gemcitabine and irinotecan in patients with platinum-refractory/resistant ovarian or primary peritoneal cancer: a phase II trialShinichi Tate, Kyoko Nishikimi, Ayumu Matsuoka, et al.
Journal of Gynecologic Oncology|January 9, 2020
Microscopic diseases remain in initial disseminated sites after neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and primary peritoneal cancerShinichi Tate, Kyoko Nishikimi, Kazuyoshi Kato, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Gynecologic Oncology|August 13, 2017
Survival and safety associated with aggressive surgery for stage III/IV epithelial ovarian cancer: A single institution observation studyShinichi Tate, Kazuyoshi Kato, Kyoko Nishikimi, et al.
Anticancer Research|April 30, 2022
Bevacizumab-based Salvage Chemotherapy Improves Survival Outcomes for Patients With Brain Metastasis from Ovarian CancerShinichi Tate, Kyoko Nishikimi, Ayumu Matsuoka, et al.
Acta Cytologica|May 22, 2022
Influence of Estradiol-Producing Ovarian Tumors on the Maturation Index of Cervical Cytology in Postmenopausal WomenAyumu Matsuoka, Shinichi Tate, Satoyo Otsuka, et al.
Cancers|August 27, 2021
Surgical Techniques and Outcomes of Colorectal Anastomosis after Left Hemicolectomy with Low Anterior Rectal Resection for Advanced Ovarian CancerKyoko Nishikimi, Shinichi Tate, Ayumu Matsuoka, et al.
In Vivo (Athens, Greece)|September 13, 2022
Validity of the 2014 FIGO Stage IIIA1 Subclassification for Ovarian, Fallopian Tube, and Peritoneal CancersAyumu Matsuoka, Shinichi Tate, Kyoko Nishikimi, et al.
Gynecologic Oncology|March 21, 2020
Metastatic peripancreatic lymph nodes resection during primary debulking surgery for primary peritoneal serous carcinomaKyoko Nishikimi, Shinichi Tate, Ayumu Matsuoka, et al.
Cancers|September 23, 2022
Serum FSH as a Useful Marker for the Differential Diagnosis of Ovarian Granulosa Cell TumorsAyumu Matsuoka, Shinichi Tate, Kyoko Nishikimi, et al.
Journal of Gynecologic Oncology|February 28, 2025
Intra- and postoperative complications associated with diaphragmatic surgery for advanced ovarian cancerKyoko Nishikimi, Shinichi Tate, Ayumu Matsuoka, et al.
Journal of Gynecologic Oncology|November 13, 2020
Tailored-dose chemotherapy with gemcitabine and irinotecan in patients with platinum-refractory/resistant ovarian or primary peritoneal cancer: a phase II trialShinichi Tate, Kyoko Nishikimi, Ayumu Matsuoka, et al.
Journal of Gynecologic Oncology|January 9, 2020
Microscopic diseases remain in initial disseminated sites after neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and primary peritoneal cancerShinichi Tate, Kyoko Nishikimi, Kazuyoshi Kato, et al.
Pageof 5